Picnic tables and benches used by families at a new play park have been taken away after they were damaged ‘beyond repair’ by vandals. Did you know with a Digital Subscription to Edinburgh News, you ...

East Lothian Council removed the seating from the children’s play area at Neilson Park, Haddington, after a series of attacks on them. It is the latest in a string of vandalism incidents to hit the ...

T.J. Watt is eager to return to the field after a dry needling mishap led to surgery for a partially collapsed lung.

Gilead Sciences Inc. (NASDAQ: GILD) on Wednesday agreed to acquire Repare Therapeutics Inc.’s (NASDAQ: RPTX) polymerase theta (Polθ) ATPase inhibitor, RP-3467. RP-3467 is being evaluated in the POLAR ...

Additionally, H.C. Wainwright reduced its price target for Repare Therapeutics from $5.00 to $3.00, while maintaining a Buy rating. This adjustment came after the presentation of initial Phase 1 ...

CAMBRIDGE, Mass. & MONTREAL, December 24, 2025--(BUSINESS WIRE)--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Michael Sullivan Michael Sullivan is a writer covering kitchen equipment and ...

An announcement from Repare Therapeutics ( (RPTX)) is now available. On December 18, 2025, Repare Therapeutics announced that Chief Scientific Officer Michael Zinda, Ph.D., had resigned effective ...

The latest announcement is out from Repare Therapeutics ( (RPTX)). Repare Therapeutics has signed an asset purchase agreement for Gilead Sciences to acquire its Polθ ATPase inhibitor RP-3467 for up to ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to ...

Investing.com -- Repare Therapeutics Inc (NASDAQ:RPTX) stock surged 18% in premarket trading Wednesday after the clinical-stage precision oncology company announced a definitive asset purchase ...